Literature DB >> 16129412

Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.

Robert Roskoski1.   

Abstract

Signaling by stem cell factor and Kit, its receptor, plays important roles in gametogenesis, hematopoiesis, mast cell development and function, and melanogenesis. Moreover, human and mouse embryonic stem cells express Kit transcripts. Stem cell factor exists as both a soluble and a membrane-bound glycoprotein while Kit is a receptor protein-tyrosine kinase. The complete absence of stem cell factor or Kit is lethal. Deficiencies of either produce defects in red and white blood cell production, hypopigmentation, and sterility. Gain-of-function mutations of Kit are associated with several human neoplasms including acute myelogenous leukemia, gastrointestinal stromal tumors, and mastocytomas. Kit consists of an extracellular domain, a transmembrane segment, a juxtamembrane segment, and a protein kinase domain that contains an insert of about 80 amino acid residues. Binding of stem cell factor to Kit results in receptor dimerization and activation of protein kinase activity. The activated receptor becomes autophosphorylated at tyrosine residues that serve as docking sites for signal transduction molecules containing SH2 domains. The adaptor protein APS, Src family kinases, and Shp2 tyrosyl phosphatase bind to phosphotyrosine 568. Shp1 tyrosyl phosphatase and the adaptor protein Shc bind to phosphotyrosine 570. C-terminal Src kinase homologous kinase and the adaptor Shc bind to both phosphotyrosines 568 and 570. These residues occur in the juxtamembrane segment of Kit. Three residues in the kinase insert domain are phosphorylated and attract the adaptor protein Grb2 (Tyr703), phosphatidylinositol 3-kinase (Tyr721), and phospholipase Cgamma (Tyr730). Phosphotyrosine 900 in the distal kinase domain binds phosphatidylinositol 3-kinase which in turn binds the adaptor protein Crk. Phosphotyrosine 936, also in the distal kinase domain, binds the adaptor proteins APS, Grb2, and Grb7. Kit has the potential to participate in multiple signal transduction pathways as a result of interaction with several enzymes and adaptor proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16129412     DOI: 10.1016/j.bbrc.2005.08.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  87 in total

1.  In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.

Authors:  Prashant Chaudhari; Sanjay Bari
Journal:  Mol Divers       Date:  2015-09-28       Impact factor: 2.943

2.  c-kit and its related genes in spermatogonial differentiation.

Authors:  Lei Zhang; Jiangjing Tang; Christopher J Haines; Huai L Feng; Liangxue Lai; Xiaoming Teng; Yibing Han
Journal:  Spermatogenesis       Date:  2011-07-01

3.  RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.

Authors:  Jeffrey W Tyner; Denise K Walters; Stephanie G Willis; Mary Luttropp; Jason Oost; Marc Loriaux; Heidi Erickson; Amie S Corbin; Thomas O'Hare; Michael C Heinrich; Michael W Deininger; Brian J Druker
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

4.  Structure of an unprecedented G-quadruplex scaffold in the human c-kit promoter.

Authors:  Anh Tuân Phan; Vitaly Kuryavyi; Sarah Burge; Stephen Neidle; Dinshaw J Patel
Journal:  J Am Chem Soc       Date:  2007-03-16       Impact factor: 15.419

5.  Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal region.

Authors:  Andrey V Reshetnyak; Bryce Nelson; Xiarong Shi; Titus J Boggon; Alevtina Pavlenco; Elizabeth M Mandel-Bausch; Francisco Tome; Yoshihisa Suzuki; Sachdev S Sidhu; Irit Lax; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

6.  Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.

Authors:  Szu-Yuan Pu; Randy Wouters; Stanford Schor; Jef Rozenski; Rina Barouch-Bentov; Laura I Prugar; Cecilia M O'Brien; Jennifer M Brannan; John M Dye; Piet Herdewijn; Steven De Jonghe; Shirit Einav
Journal:  J Med Chem       Date:  2018-07-16       Impact factor: 7.446

7.  Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade.

Authors:  Noria Harir; Cédric Boudot; Katrin Friedbichler; Karoline Sonneck; Rudin Kondo; Séverine Martin-Lannerée; Lukas Kenner; Marc Kerenyi; Saliha Yahiaoui; Valérie Gouilleux-Gruart; Jean Gondry; Laurence Bénit; Isabelle Dusanter-Fourt; Kaïss Lassoued; Peter Valent; Richard Moriggl; Fabrice Gouilleux
Journal:  Blood       Date:  2008-06-25       Impact factor: 22.113

8.  Spatial and temporal expression of c-Kit in the development of the murine submandibular gland.

Authors:  Xuejiu Wang; Senrong Qi; Jinsong Wang; Dengsheng Xia; Lizheng Qin; Zongmei Zheng; Liping Wang; Chunmei Zhang; Luyuan Jin; Gang Ding; Songlin Wang; Zhipeng Fan
Journal:  J Mol Histol       Date:  2014-02-20       Impact factor: 2.611

9.  Glycogen synthase kinase 3beta activation is a prerequisite signal for cytokine production and chemotaxis in human mast cells.

Authors:  Madeleine Rådinger; Hye Sun Kuehn; Mi-Sun Kim; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

Review 10.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.